文献类型：期刊文献

中文题名：基于CiteSpace的中医药治疗围绝经期综合征的可视化分析

英文题名：Visual analysis of traditional Chinese medicine treatment of perimenopausal syndrome based on CiteSpace

作者：王天琳[1];胡诗宛[1];赵林华[2];张伟[3]

第一作者：王天琳

机构：[1]北京中医药大学研究生院,北京100029;[2]中国中医科学院广安门医院代谢病研究所,北京100053;[3]甘肃中医药大学基础医学院,甘肃兰州730000

第一机构：北京中医药大学研究生院,北京100029

年份：2023

卷号：20

期号：3

起止页码：20

中文期刊名：中国医药导报

外文期刊名：China Medical Herald

收录：CSTPCD

基金：中医药创新团队及人才支持计划国家中医药多学科交叉创新团队项目(ZYYCXTD-D-202001);中国中医科学院科技创新工程项目(CI2021A01605)。

语种：中文

中文关键词：CiteSpace;中医药;围绝经期综合征;知识图谱;可视化

外文关键词：CiteSpace;Traditional Chinese medicine;Perimenopausal syndrome;Knowledge graph;Visualization

摘要：目的 探究近20年中医药治疗围绝经期综合征(PMPS)相关文献的研究热点和发展趋势。方法 以中国知网数据库为数据来源检索2000年1月至2022年1月中医药治疗PMPS的相关文献,应用CiteSpace软件对纳入文献的作者,研究机构和关键词进行可视化分析。结果 共纳入2 678篇文献,核心作者以金亚蓓、王静、王秀霞为代表,国内尚未形成核心团队,研究机构以中医药大学及其附属医院为主。关键词相关图谱显示,中医药治疗PMPS的主要手段是以二仙汤为首的中药复方治疗及非药物疗法的针刺治疗。研究热点涉及神经内分泌免疫网络。结论 中医药治疗PMPS的研究主要集中在对内服中药复方和中成药临床干预效果,亟须建立标准化治疗方案。
Objective To explore the research hotspot and development trend of traditional Chinese medicine treatment of perimenopausal syndrome(PMPS) in recent 20 years. Methods The literature on PMPS treated by traditional Chinese medicine from January 2000 to January 2022 was retrieved from CNKI data, CiteSpace software was used to visualize the authors, research institutions, and key words of the included literature. Results A total of 2 678 literatures were included,and the core authors were represented by Jin Yabei, Wang Jing, and Wang Xiuxia. The core team had not been formed in China, and the research institutions were mainly the university of traditional Chinese medicine, and its affiliated hospitals.Key words correlation atlas showed that the main means of traditional Chinese medicine treatment for PMPS were traditional Chinese medicine compound therapy led by Erxian Decoction and acupuncture therapy of non-drug therapy. The research focused on neuroendocrine immune network. Conclusion The research of PMPS treatment in traditional Chinese medicine mainly focuses on the clinical intervention effect of traditional Chinese medicine compound and proprietary medicine, and it is urgent to establish a standardized treatment scheme.